At INTERPHEX 2026, innovation is not only showcased, it is evaluated, challenged, and recognized by the broader life sciences community. As one of the industry’s leading events focused on pharmaceutical and bioprocessing technology, INTERPHEX brings together solution providers and decision-makers across the full product lifecycle, from development through commercial manufacturing.
Within this environment, recognition carries weight. The INTERPHEX Exhibitor Awards program highlights technologies that demonstrate meaningful advancement in performance, usability, and impact across biopharma operations.
Ensorcell is proud to announce that the Versaweld™ sterile tube welder has been named Best New Product/Service of 2026. This recognition underscores both the platform’s technical innovation and its alignment with evolving bioprocessing workflows and life science manufacturing needs.
The Best New Product/Service category recognizes newly introduced technologies that demonstrate excellence in innovation, application, and potential industry impact. Past recipients have introduced meaningful advances in bioprocessing equipment, automation, and digital integration, reflecting the award’s focus on solutions that improve efficiency and enable more scalable operations.
Recognition of the Versaweld platform reflects the growing demand for solutions that address critical challenges in modern biomanufacturing. Versaweld enables reliable sterile tube welding while improving efficiency and operational flexibility. Its enclosed system eliminates the need for sharps, supporting safer workflows, while its cost-efficient design ensures superb value with cost accessibility and makes advanced sterile connection capabilities more accessible without compromising performance.
The Versaweld platform was developed by the team at Ensorcell and our Re:Build Manufacturing affiliates to address long-standing constraints in sterile fluid handling across research, development, and manufacturing environments.
Designed as a portable sterile tube welder for modern workflows, Versaweld combines mobility, versatility, and operational simplicity in a compact system that supports evolving biopharmaceutical manufacturing workflows.
Key capabilities include:
These features reflect a broader shift that Ensorcell is seeking to drive in life science tools toward systems that are not only high-performing, but also intuitive, flexible, and scalable across environments.
The recognition of Versaweld at INTERPHEX comes at a time when the life sciences industry is placing increased emphasis on process efficiency, contamination control, and operational flexibility.
Manufacturers are seeking bioprocessing equipment for sterile connections that can support:
Versaweld addresses these priorities through its enclosed cutting system, modular cassette design, and ability to handle multiple tubing types without complex changeover. These capabilities support more efficient operations while maintaining the integrity required for regulated environments.
This award coincides with the formal launch of the Versaweld at INTERPHEX 2026, where Ensorcell is introducing the system to professionals across pharmaceutical, bioprocessing, and advanced therapy sectors.
Commenting on the award, Andria Balogh, Head of Products and Marketing at Ensorcell, shared:
“We are honored to receive INTERPHEX’s Best New Product/Service award for Versaweld. This recognition reflects the thoughtful work of our engineering and product teams, and our commitment to solving real challenges for scientists and manufacturers.
At Ensorcell, our team is grounded in delivering superb value, ensuring that high-quality, high-performance tools are accessible across the life sciences ecosystem. Versaweld exemplifies that vision by combining innovation, usability, and cost efficiency in a way that enables broader adoption and ultimately supports better outcomes for patients.”
As the life sciences industry continues to evolve, driven by advances in biologics, cell and gene therapy, and increasingly complex manufacturing systems, the demand for flexible, efficient, and accessible tools will continue to grow.
The Versaweld award highlights a broader shift toward bioprocessing solutions that deliver not only technical performance, but also operational and economic value. For Ensorcell, this moment reinforces a clear direction to continue developing technologies that expand access, improve efficiency, and support the next generation of scientific and medical progress.
In a field where precision and performance are essential, recognition for innovation matters. When that innovation also improves accessibility and usability, its impact extends further, across laboratories, manufacturing environments, and ultimately to the patients these systems are designed to serve.
